Clonal Restriction of Platelet-associated Anti-GPIIb/IIIa Autoantibodies in Patients with Chronic ITP

Robert McMillan; Jennifer Lopez-Dee; Ronald Bowditch

doi:10.1055/s-0037-1615754

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2001; 85(05): 821-823
DOI: 10.1055/s-0037-1615754

Review Article

Schattauer GmbH

Clonal Restriction of Platelet-associated Anti-GPIIb/IIIa Autoantibodies in Patients with Chronic ITP

Authors

Robert McMillan

¹The Scripps Research Institute, La Jolla, California, USA, and the University of Oklahoma, Oklahoma City, Oklahoma, USA
Jennifer Lopez-Dee

¹The Scripps Research Institute, La Jolla, California, USA, and the University of Oklahoma, Oklahoma City, Oklahoma, USA
Ronald Bowditch

¹The Scripps Research Institute, La Jolla, California, USA, and the University of Oklahoma, Oklahoma City, Oklahoma, USA

Abstract

Summary

Chronic immune thrombocytopenic purpura is due to platelet destruction induced by autoantibodies against platelet surface antigens. Prior studies show that some serum autoantibodies are light-chain restricted, suggesting a clonal origin. Since plasma and platelet-associated antibody from the same patient may bind to different epitopes, it is important to evaluate the clonality of platelet-associated antibody. Platelet-associated autoantibodies from 28 ITP patients were studied. Of 23 platelet-associated antibodies tested directly, 16 showed significant light chain restriction (7 complete and 9 partial) when compared to plasma IgG light chain distribution. Similarly, 9 of 12 platelet-associated antibody eluates were light chain restricted, 5 complete and 4 partial. In all cases where platelet-associated antibody and antibody eluate from the same patient were studied, the results were concordant. We conclude that a significant proportion of platelet-associated antibodies from ITP patients show apparent clonality, as evaluated by light chain restriction. These results are consistent with other studies in ITP suggesting a limited antigenic repertoire.

Keywords

ITP - autoantibody - platelet - clonality

Volltext

Referenzen

References
1 George JN, El-Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ. editors. Williams Hematology. New York: McGraw-Hill; 1995: 1315-5.
2 Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997; 349: 1531-6.
3 McMillan R, Imbach P. Immune thrombocytopenia. In: Schafer AI, Loscalzo J. editors. Thrombosis and Hemorrhage. Cambridge, MA: Blackwell Scientific Publications, Inc.; 1998: 643-64.
4 Rosse WF, Adams JP, Yount WJ. Subclasses of IgG antibodies in immune thrombocytopenic purpura. Br J Haematol 1980; 46: 109-14.
5 Hymes K, Schur PH, Karpatkin S. Heavy-chain subclass of bound anti-platelet IgG in autoimmune thrombocytopenic purpura. Blood 1980; 56: 84-7.
6 Helmerhorst FM, van Leeuwen EF, Pegels JG. et al. Primary and secondary autoimmune thrombocytopenia. A serological and clinical analysis. Scand J Haematol 1982; 28: 319-28.
7 Gearhart CG, Sigal NH, Klinman NR. Production of antibodies of identical idiotype but diverse immunoglobulin classes by cells derived from a single stimulated B cell. Proc Natl Acad Sci 1975; 72: 1707-11.
8 Sinha RK, Kelton JG. Current controversies concerning the measurement of platelet-associated IgG. Trans Med Rev 1990; 4: 121-35.
9 George JN. Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of α-granule proteins. Blood 1990; 76: 859-70.
10 Fujisawa K, Tani P, O’Toole TE. et al. Different specificities of platelet-associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic ITP. Blood 1992; 79: 1441-6.
11 Stockelberg D, Hou M, Jacobsson S. et al. Evidence for a light chain restriction of glycoprotein Ib/IX and IIb/IIIa reactive antibodies in chronic idiopathic thrombocytopenic purpura. Br J Haematol 1995; 90: 175-9.
12 Stockelberg D, Hou M, Jacobsson S. et al. Light chain-restricted autoanti-bodies in chronic idiopathic thrombocytopenic purpura, but no evidence for circulating clonal B-lymphocytes. Ann Hematol 1996; 72: 29-34.
13 Christie DJ, Sauro SC, Fairbanks KD, Kay NE. Detection of clonal platelet antibodies in immunologically-mediated thrombocytopenias: association with circulating clonal/oligclonal B cells. Br J Haematol 1993; 85: 277-84.
14 Varon D, Karpatkin S. A monoclonal antiplatelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets. Proc Natl Acad Sci USA 1983; 80: 6992-5.
15 Nugent DJ. Human monoclonal antibodies in the characterization of platelet antigens. In: Kunicki T, George JN. editors. Platelet immunobiology: molecular and clinical aspects. Philadelphia: Lippincott; 1989: 273-90.
16 Hou M, Stockelberg D, Kutti J, Wadenvik H. Glycoprotein IIb/IIIa autoantigenic repertoire in chronic idiopathic thrombcytopenic purpura. Br J Haematol 1995; 91: 971-5.
17 Escher R, Muller D, Vogel M. et al. Recombinant human natural autoanti-bodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP. Br J Haematol 1998; 102: 820-8.
18 He R, Reid DM, Jones CE, Shulman NR. Extracellular epitopes of platelet glycoprotein Iba reactive with serum antibodies from patients with chronic idiopathic thrombocytopenic purpura. Blood 1995; 86: 3789-96.
19 Bye JM, Carter C, Cui Y. et al. Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. J Clin Invest 1992; 90: 2481-90.
20 Roben P, Barbas SM, Sandoval L. et al. Repertoire cloning of lupus anti-DNA autoantibodies. J Clin Invest 1996; 98: 2827-37.
21 Van der Harst D, de Jong D, Limpens J. et al. Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura. Blood 1990; 76: 2321-6.